YONGIN, South Korea, Oct. 28, 2024 /PRNewswire/ — GC Biopharma announced that it has signed an agreement with Novelty Nobility, a biotech company specializing in the development of antibody-based therapeutics, for the joint research and development of a novel treatment for geographic…
